Share This Article:
Identifiable biomarkers may provide objective evidence in proving a Long COVID claim. A recent report highlights developments in identifying the risk of Long COVID through immune profiling.
SARS-CoV-2 infection can result in the development of a constellation of persistent sequelae following acute disease called post-acute sequelae of COVID-19 (PASC) or Long COVID1–3.
Individuals diagnosed with Long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions1–3; however, the basic biological mechanisms responsible for these debilitating symptoms are unclear.
By Jon L. Gelman
Courtesy of Workers' Compensation
Read Also
- Aug 12, 2024
- Frank Ferreri
- Aug 06, 2024
- Frank Ferreri
About The Author
About The Author
- WorkersCompensation.com
More by This Author
- Oct 02, 2024
- WorkersCompensation.com
- Jun 24, 2024
- WorkersCompensation.com
- May 11, 2023
- WorkersCompensation.com
Read More
- Aug 12, 2024
- Frank Ferreri
- Aug 06, 2024
- Frank Ferreri
- Aug 05, 2024
- Frank Ferreri
- Aug 02, 2024
- Frank Ferreri
- Jul 01, 2024
- Frank Ferreri